Drug rehabilitation does not follow one universal sequence for every person. Modern addiction care is better understood as a continuing, person-centred process: assessment, the safest suitable level of care, active treatment, reassessment, transition and ongoing recovery support.
Some people enter treatment through an outpatient clinic. Others first need hospital care, withdrawal management or residential support. The order, intensity and duration should change when the person’s risks and needs change.
Medical note: Abruptly stopping alcohol, benzodiazepines or some other substances can be dangerous. Severe confusion, seizures, hallucinations, loss of consciousness, overdose or immediate risk of harm require urgent medical care.
Why “phases” are a guide, not a fixed timetable
Older explanations often describe detox, rehabilitation and aftercare as three simple stages. That can be useful as a basic outline, but it may hide important differences between patients. Not everyone needs detox. Some people need medication before counselling can be effective. Others need treatment for psychosis, depression, trauma, chronic pain or medical illness at the same time.
The American Society of Addiction Medicine describes addiction treatment as a continuum of care. A comprehensive assessment is used to recommend the least intensive level that is still safe and able to meet the person’s needs. The person is then reassessed to decide whether to continue, step down or move to a more intensive setting.
Phase 1: Engagement and immediate safety
The first task is to establish whether there is an urgent problem and help the person enter care. This may involve:
- screening for substance use and immediate risks;
- overdose response and access to emergency care;
- assessment of suicidal thoughts, violence risk, psychosis or severe confusion;
- addressing urgent medical problems, pregnancy or medication interactions;
- motivational conversations that respect the person’s goals and readiness;
- help with practical barriers such as transport, cost, childcare, work or family responsibilities.
Engagement should not depend on a person first proving that they are “fully motivated.” Motivation can change, and respectful treatment can help strengthen it.
Phase 2: Comprehensive assessment and treatment planning
A proper assessment goes beyond asking which drug is used. It should consider:
- substances, dose, frequency, route and pattern of use;
- withdrawal history, seizures, delirium, blackouts and overdose;
- prescribed medicines and physical-health conditions;
- depression, anxiety, trauma, psychosis, cognitive problems and suicide risk;
- family relationships, housing, work, legal issues and recovery environment;
- previous treatment, medication and periods of improvement;
- the patient’s preferences, culture, values and practical constraints.
The result should be an individual treatment plan with clear priorities, responsible clinicians and a plan for review. A standard package for everyone is not person-centred care.
Phase 3: Withdrawal management and stabilisation—when needed
Withdrawal management helps a person safely reduce or stop a substance and manage acute symptoms. It is needed for some patients, not all. The appropriate setting may be outpatient, residential or hospital-based depending on the substance, previous withdrawal complications, physical health, mental state and available support.
Detoxification is not the full treatment. SAMHSA materials for families explicitly describe detox as a first step that can prepare a person for treatment. Before withdrawal management ends, the next appointment, medication plan and continuing treatment should already be arranged.
For opioid use disorder, short-term withdrawal alone can leave a person with reduced tolerance and a high risk of returning to use and overdosing. Evidence-based medication treatment should be discussed rather than assuming that becoming opioid-free immediately is the only valid goal.
Phase 4: Active treatment
Active treatment addresses the substance use disorder and the conditions that maintain it. Depending on the diagnosis, it can include:
- medications for opioid, alcohol or tobacco use disorders where appropriate;
- cognitive-behavioural therapy and relapse-prevention skills;
- motivational interviewing or motivational enhancement;
- contingency management, particularly for stimulant use disorders;
- family or couples treatment;
- treatment for co-occurring mental-health and physical-health conditions;
- peer, spiritual or mutual-support options chosen by the person;
- support with housing, work, education, finances and legal problems.
Treatment may occur through outpatient, intensive outpatient, residential or medically managed inpatient care. A person should not remain in a setting simply because a programme sells a fixed number of days; the level of care should be reviewed against current clinical needs.
Phase 5: Progress review and adjustment
Progress is more than a single drug test. Review may consider:
- changes in substance use, overdose risk and cravings;
- attendance and engagement;
- physical and mental health;
- medication response and side effects;
- sleep, daily routine and functioning;
- family, housing, work and legal stability;
- the patient’s own goals and quality of life.
If progress is limited, the response should be reassessment—not blame or automatic discharge. The plan may need a different therapy, medication, more frequent contact, a safer environment or a higher level of care.
Phase 6: Transition and discharge planning
Discharge should be planned rather than treated as the day a person “finishes rehab.” A safe transition may include:
- confirmed follow-up appointments;
- continued access to prescribed medication;
- a written plan for cravings, renewed use and overdose risk;
- naloxone and overdose education when opioids are involved;
- family or supporter involvement with the person’s consent;
- housing, work and legal support;
- clear information about how to return to treatment quickly.
Moving from residential to outpatient care is a change in intensity, not the end of recovery support.
Phase 7: Continuing care and recovery support
Recovery often requires long-term support. Continuing care can include medication, therapy, regular recovery check-ups, peer groups, family support and rapid re-engagement after warning signs. ASAM’s current continuum includes long-term remission monitoring, reflecting a chronic-care approach rather than a one-time episode.
A return to substance use can be serious, particularly after tolerance has fallen. It does not mean that all previous progress has disappeared or that treatment is hopeless. It signals the need to reassess safety and strengthen or change the care plan.
How families can support each phase
- Encourage assessment rather than trying to choose the level of care without professional input.
- Ask the programme to explain the diagnosis, treatment plan and review process.
- Support medication when it is clinically recommended; do not describe evidence-based medication as “replacing one addiction with another.”
- Learn overdose and emergency warning signs.
- Agree on practical boundaries that protect safety without humiliation or coercion.
- Participate in family sessions when appropriate and consented to.
- Prepare for long-term follow-up rather than expecting a fixed stay to solve every problem.
Questions to ask a rehabilitation programme
- How is the initial assessment completed and by whom?
- How do you decide between outpatient, residential and hospital care?
- Who manages withdrawal and medical emergencies?
- Which evidence-based therapies and medications are available?
- How often is the treatment plan reviewed?
- What happens if the patient uses substances during treatment?
- How are co-occurring mental-health conditions treated?
- What is the written discharge and continuing-care plan?
- How can the patient return quickly if risks increase?
Authoritative sources
- American Society of Addiction Medicine: The ASAM Criteria, Fourth Edition
- ASAM: Assessment and Reassessment Guides
- National Institute on Drug Abuse: Principles of Drug Addiction Treatment
- SAMHSA: What Is Substance Abuse Treatment? A Booklet for Families
- World Health Organization: mhGAP Guideline, Third Edition
Last clinically reviewed: 29 July 2026.